Human Genome Epidemiology Literature Finder
|
Records 1 - 29 (of 29 Records) |
| Query Trace: Carcinoma and CYP3A5[original query] |
|---|
| Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa. Pharmacogenetics 2004 Oct 14 (10): 691-700. Wojnowski Leszek, Turner Paul C, Pedersen Bonnie, Hustert Elisabeth, Brockmöller Jürgen, Mendy Maimuna, Whittle Hilton C, Kirk Greg, Wild Christopher |
| Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Sep 14 (9): 2183-90. Starr Jacqueline R, Chen Chu, Doody David R, Hsu Li, Ricks Sherianne, Weiss Noel S, Schwartz Stephen |
| Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer. British journal of clinical pharmacology 2005 Apr 59 (4): 415-24. Zhou Qingyu, Sparreboom Alex, Tan Eng-Huat, Cheung Yin-Bun, Lee Ann, Poon Donald, Lee Edmund J D, Chowbay Balr |
| Gene-environment interaction: the role of SULT1A1 and CYP3A5 polymorphisms as risk modifiers for squamous cell carcinoma of the oesophagus. Carcinogenesis 2006 Apr 27 (4): 791-7. Dandara Collet, Li Dong-Ping, Walther Gabi, Parker M Iqb |
| Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers. International journal of clinical oncology 2007 Aug 12 (4): 284-90. Jiko Mari, Yano Ikuko, Sato Eriko, Takahashi Kazushige, Motohashi Hideyuki, Masuda Satohiro, Okuda Masahiro, Ito Noriyuki, Nakamura Eijiro, Segawa Takehiko, Kamoto Toshiyuki, Ogawa Osamu, Inui Ken-Ic |
| Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinoma. European journal of cancer (Oxford, England : 1990) 2009 Sep 45 (13): 2316-23. Thomas Fabienne, Rochaix Philippe, White-Koning Melanie, Hennebelle Isabelle, Sarini Jérôme, Benlyazid Adil, Malard Laurence, Lefebvre Jean-Louis, Chatelut Etienne, Delord Jean Pier |
| Population analysis of erlotinib in adults and children reveals pharmacokinetic characteristics as the main factor explaining tolerance particularities in children. Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Jul 17 (14): 4862-71. White-Koning Melanie, Civade Elodie, Geoerger Birgit, Thomas Fabienne, Le Deley Marie-Cécile, Hennebelle Isabelle, Delord Jean-Pierre, Chatelut Etienne, Vassal Gill |
| The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients. Cancer chemotherapy and pharmacology 2011 Jun 67 (6): 1471-8. Chew Sin-Chi, Singh Onkar, Chen Xiangai, Ramasamy Rathi Devi, Kulkarni Tejal, Lee Edmund J D, Tan Eng-Huat, Lim Wan-Teck, Chowbay Balr |
| Study the polymorphism of CYP3A5 and CYP3A4 loci in Iranian population with laryngeal squamous cell carcinoma. Molecular biology reports 2011 Nov 38 (8): 5443-8. Azarpira Negar, Ashraf Mohamad Javad, Khademi Bigan, Darai Masumeh, Hakimzadeh Afsoon, Abedi Elh |
| Population pharmacokinetic analysis of sorafenib in patients with solid tumours. British journal of clinical pharmacology 2011 Aug 72 (2): 294-305. Jain Lokesh, Woo Sukyung, Gardner Erin R, Dahut William L, Kohn Elise C, Kummar Shivaani, Mould Diane R, Giaccone Giuseppe, Yarchoan Robert, Venitz Jürgen, Figg William |
| Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study. The Lancet. Oncology 2011 Nov 12 (12): 1143-50. Garcia-Donas Jesus, Esteban Emilio, Leandro-García Luis Javier, Castellano Daniel E, del Alba Aranzazu González, Climent Miguel Angel, Arranz José Angel, Gallardo Enrique, Puente Javier, Bellmunt Joaquim, Mellado Begoña, Martínez Esther, Moreno Fernando, Font Albert, Robledo Mercedes, Rodríguez-Antona Cristi |
| Risk factors for sorafenib-induced high-grade skin rash in Japanese patients with advanced renal cell carcinoma. Anti-cancer drugs 2012 Dec . Tsuchiya N, Narita S, Inoue T, Hasunuma N, Numakura K, Horikawa Y, Satoh S, Notoya T, Fujishima N, Hatakeyama S, Ohyama C, Habuchi T |
| Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients. Cancer chemotherapy and pharmacology 2013 Oct 72 (4): 825-35. Kim Hye Ryun, Park Hyung Soon, Kwon Woo Sun, Lee Ji Hyun, Tanigawara Yusuke, Lim Sun Min, Kim Hyo Song, Shin Sang Jun, Ahn Jung Bae, Rha Sun You |
| Association of CYP3A4, CYP3A5 polymorphisms with lung cancer risk in Bangladeshi population. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Feb 35 (2): 1671-8. Islam Mohammad Safiqul, Mostofa A G M, Ahmed Maizbha Uddin, Bin Sayeed Muhammad Shahdaat, Hassan Md Rajib, Hasnat Ab |
| Genetic variants in sex hormone metabolic pathway genes and risk of esophageal squamous cell carcinoma. Carcinogenesis 2013 Jan . Hyland PL, Freedman ND, Hu N, Tang ZZ, Wang L, Wang C, Ding T, Fan JH, Qiao YL, Golozar A, Wheeler W, Yu K, Yuenger J, Burdette L, Chanock SJ, Dawsey SM, Tucker MA, Goldstein AM, Abnet CC, Taylor PR |
| Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib. Acta oncologica (Stockholm, Sweden) 2014 Oct 53 (10): 1413-22. Beuselinck Benoit, Lambrechts Diether, Van Brussel Thomas, Wolter Pascal, Cardinaels Nina, Joniau Steven, Lerut Evelyne, Karadimou Alexandra, Couchy Gabrielle, Sebe Philippe, Ravaud Alain, Zerbib Marc, Caty Armelle, Paridaens Robert, Schöffski Patrick, Verkarre Virginie, Berger Julien, Patard Jean-Jacques, Zucman-Rossi Jessica, Oudard Stépha |
| CYP3A5 and ABCB1 polymorphisms as predictors for sunitinib outcome in metastatic renal cell carcinoma. European urology 2015 Oct 68 (4): 621-9. Diekstra Meta H M, Swen Jesse J, Boven Epie, Castellano Daniel, Gelderblom Hans, Mathijssen Ron H J, Rodríguez-Antona Cristina, García-Donas Jesus, Rini Brian I, Guchelaar Henk-J |
| Effect of the CYP3A5 and ABCB1 genotype on exposure, clinical response and manifestation of toxicities from sunitinib in Asian patients. The pharmacogenomics journal 2015 Mar . Teo Y L, Wee H L, Chue X P, Chau N M, Tan M-H, Kanesvaran R, Wee H L, Ho H K, Chan |
| Clinical effects of single nucleotide polymorphisms on drug-related genes in Japanese metastatic renal cell carcinoma patients treated with sunitinib. Anti-cancer drugs 2016 Aug . Numakura Kazuyuki, Tsuchiya Norihiko, Kagaya Hideaki, Takahashi Makoto, Tsuruta Hiroshi, Inoue Takamitsu, Narita Shintaro, Huang Mingguo, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono |
| Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma. Oncotarget 2016 May . Zhou Jun, Wen Qiang, Li Sai-Fei, Zhang Yun-Fei, Gao Na, Tian Xin, Fang Yan, Gao Jie, Cui Ming-Zhu, He Xiao-Pei, Jia Lin-Jing, Jin Han, Qiao Hai-Li |
| SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma. Pharmacogenomics 2016 Mar . Duran Ignacio, Hagen Carlos, Arranz José Ángel, Apellaniz-Ruiz María, Pérez-Valderrama Begoña, Sala Nuria, Lainez Nuria, García-Del Muro Xavier, Noguerón Esther, Climent Miguel Ángel, Maroto Pablo, Font Albert, García-Donas Jesús, Gallardo Enrique, López-Criado Pilar, González Del Alba Aránzazu, Sáez María Isabel, Vázquez Sergio, Luque Raquel, Rodríguez-Antona Cristi |
| Gene Variations of Sixth Complement Component Affecting Tacrolimus Metabolism in Patients with Liver Transplantation for Hepatocellular Carcinoma. Chinese medical journal 2017 Jul 130 (14): 1670-1676. Liao Jian-Hua, Li Chang-Can, Wu Shao-Han, Fan Jun-Wei, Gu Hai-Tao, Wang Zhao-W |
| Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer. Cancer chemotherapy and pharmacology 2017 Jul . Mbatchi Litaty C, Gassiot Matthieu, Pourquier Philippe, Goberna Alejando, Mahammedi Hakim, Mourey Loic, Joly Florence, Lumbroso Serge, Evrard Alexandre, Houede Nadi |
| Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma. European urology focus 2016 Dec 2 (6): 633-639. de Velasco Guillermo, Gray Kathryn P, Hamieh Lana, Urun Yuksel, Carol Hallie A, Fay Andre P, Signoretti Sabina, Kwiatkowski David J, McDermott David F, Freedman Matthew, Pomerantz Mark M, Choueiri Toni |
| ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinib. Acta clinica Belgica 2018 May 1-9. Werbrouck Emilie, Bastin Julie, Lambrechts Diether, Verbiest Annelies, Van Brussel Thomas, Lerut Evelyne, Machiels Jean-Pascal, Verschaeve Vincent, Richard Vincent, Debruyne Philip R, Decallonne Brigitte, Schöffski Patrick, Bechter Oliver, Wolter Pascal, Beuselinck Beno |
| Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma. Medical oncology (Northwood, London, England) 2018 Mar 35 (4): 51. Igarashi Ryoma, Inoue Takamitsu, Fujiyama Nobuhiro, Tsuchiya Norihiko, Numakura Kazuyuki, Kagaya Hideaki, Saito Mitsuru, Narita Shintaro, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono |
| CYP3A5 is unlikely to mediate anticancer drug resistance in hepatocellular carcinoma. Pharmacogenomics 2019 10 20 (15): 1085-1092. Lauschke Volker M, Nordling Åsa, Zhou Yitian, Fontalva Sara, Barragan Isabel, Ingelman-Sundberg Magn |
| Relevance of CYP3A5 Expression on the Clinical Outcome of Patients With Renal Cell Carcinoma. Anticancer research 2021 5 41 (5): 2511-2521. Matsumoto Jun, Kotera Yumi, Watari Shogo, Takeuchi Koichi, Ueki Hideo, Koyama Toshihiro, Wada Koichiro, Fujiyoshi Masachika, Nasu Yasutomo, Ariyoshi Norita |
| Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients. Frontiers in pharmacology 2022 9 13 954242. Cao Peng, Guo Wei, Wang Jun, Wu Sanlan, Huang Yifei, Wang Yang, Liu Yani, Zhang |
- Page last reviewed:Feb 1, 2024
- Content source: